Zuhal Butuner

Company: Sepul Bio

Job title: Chief Medical Officer

Seminars:

Advancing mRNA Therapies in Rare Ophthalmic Disorders: Lessons from Clinical Development 10:30 am

Differentiate mRNA therapies from DNA-based gene therapies, highlighting unique opportunities and challenges in ocular indications Share lessons learned from rare disease trial execution, including patient population considerations and regulatory navigation Explore the role of novel and alternative endpoints in inherited retinal disorder studies to better capture efficacyRead more

day: Conference Day Two